Home / Companies / Avid Bioservices, Inc. / 30 Jan 2025
Avid Bioservices, Inc.: meeting of 30 Jan 2025
Votes reported on Form N-PX, item by item
294 Form N-PX filers reported votes at the Avid Bioservices, Inc. meeting of 30 Jan 2025. Their records fall into 4 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.
foragainstabstain, withhold or otheramber tick: the portion cast against management
Items
SECTION 14A SAY-ON-PAY VOTESIssuer
Advisory vote on executive pay (say-on-pay)
392 vote records from 285 filers. 75 of the 274 filers that marked the item either way voted against management. 11 filers reported this item without a management mark.
EXTRAORDINARY TRANSACTIONSIssuer
EXTRAORDINARY TRANSACTIONS: management items
Management items in this category are shown together; filers word and number them differently.
130 vote records from 70 filers. 0 of the 70 filers that marked the item either way voted against management.
COMPENSATIONIssuer
COMPENSATION: management items
Management items in this category are shown together; filers word and number them differently.
6 vote records from 6 filers. 1 of the 6 filers that marked the item either way voted against management.
CORPORATE GOVERNANCEIssuer
CORPORATE GOVERNANCE: management items
Management items in this category are shown together; filers word and number them differently.
177 vote records from 87 filers. 10 of the 87 filers that marked the item either way voted against management.
How the largest families voted
| Family | 1. Say-on-pay |
|---|---|
| Vanguard | For |
| BlackRock and iShares | For |
| Fidelity | For |
| Dimensional | Against * |
| State Street and SPDR | For |
| Franklin Templeton | For |
| Invesco | For |
| Equitable | For |
| Charles Schwab | Against * |
| Nuveen and TIAA | Against * |
| ProShares and ProFunds | For |
| John Hancock and Manulife | For |
| Morgan Stanley, Eaton Vance and Calvert | For |
| Goldman Sachs | For |
| WisdomTree | For |
| PGIM and Prudential | Against * |
| Jackson National funds | For |
| Northern Trust and FlexShares | Against * |
| SEI | Against * |
| T. Rowe Price | For |
| Lincoln Financial | For |
| Voya | Abstain or withhold * |
| First Trust | For |
| Russell Investments | Against * |
| Nationwide | For |
| Victory Capital | For |
| Brighthouse Funds | For |
| Guggenheim and Rydex | For |
| Columbia Threadneedle | For |
| BNY Mellon | For |
| Principal | For |
| Pacific Life funds | For |
| Global X | Against * |
| AllianceBernstein | Against * |
| DWS | For |
| MassMutual | For |
| Harbor Funds | For |
| Virtus | For |
| Neuberger Berman | For |
| Natixis and Loomis Sayles | Against * |
* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.
Questions
How did large funds vote at the Avid Bioservices, Inc. meeting?
294 Form N-PX filers reported votes at the meeting of 30 Jan 2025. On say-on-pay, 75 of 274 voted against management (27.4%). The family table lists each of the largest families item by item.
Is this the meeting result?
No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by Avid Bioservices, Inc. on Form 8-K.
Why are director elections shown as counts only?
Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.
Every meeting on file for Avid Bioservices, Inc.
Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing Avid Bioservices, Inc. with a meeting date within three days of 30 Jan 2025. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 30 Sep 2026.